Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis

被引：0
|
作者：
Qiu-Feng He
Qiong-Fang Zhang
Da-Zhi Zhang
机构：
[1] Chongqing Medical University,Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital
来源：
Digestive Diseases and Sciences | 2016年 / 61卷
关键词：
Genotype 1 hepatitis C; Sofosbuvir; Ledipasvir; Ribavirin; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3108 / 3117
页数：9
相关论文
共 50 条
  • [1] Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis
    He, Qiu-Feng
    Zhang, Qiong-Fang
    Zhang, Da-Zhi
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) : 3108 - 3117
  • [2] Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis
    Tao, Tingting
    Jiang, Xuehua
    Chen, Yuehong
    Song, Yiran
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 55 : 56 - 71
  • [3] Ledipasvir/sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotype 1: A pairwise meta-analysis
    Ferreira, Vinicius L.
    Assis Jarek, Nayara A.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Wiens, Astrid
    Muzzillo, Dominique A.
    Pontarolo, Roberto
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 749 - 755
  • [4] Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis
    Ahmed, Hussien
    Elgebaly, Ahmed
    Abushouk, Abdelrahman Ibrahim
    Hammad, Ali Mohamed
    Attia, Attia
    Negida, Ahmed
    [J]. ANTIVIRAL THERAPY, 2017, 22 (05) : 369 - 379
  • [5] The Efficacy and Safety of 12 Weeks of Sofosbuvir and Ledipasvir versus Sofosbuvir, Ledipasvir, and Ribavirin in Patients with Chronic Hepatitis C, Genotype 1, Who Have Cirrhosis and Have Failed Prior Therapy: A Systematic Review and Meta-Analysis
    Stokes, William
    Fenton, Carol
    Clement, Fiona
    James, Matthew
    Ronksley, Paul
    Tang, Karen L.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 2017
  • [6] Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2
    Sugimoto, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Imoto, Susumu
    Kim, Chi Wan
    Tanaka, Yasuhito
    Kudo, Masatoshi
    Yano, Yoshihiko
    Hayashi, Yoshitake
    [J]. DIGESTIVE DISEASES, 2016, 34 (06) : 627 - 631
  • [7] Efficacy of Ledipasvir plus Sofosobuvir with or without ribavirin in hepatitis C genotype 1 patients who failed previous treatment with Simeprevir plus Sofosbuvir
    Gonzales, Gabriel R.
    Gonzalez, Stevan A.
    Nazario, Hector E.
    Gautam, Manjushree
    Barnes, Maisha
    Mantry, Parvez S.
    Weinstein, Jeffrey S.
    Ndungu, Milka
    Teachenor, Olga
    Modi, Apurva A.
    [J]. HEPATOLOGY, 2015, 62 : 775A - 775A
  • [8] Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis
    Modi, Apurva A.
    Nazario, Hector
    Trotter, James F.
    Gautam, Manjushree
    Weinstein, Jeffrey
    Mantry, Parvez
    Barnes, Maisha
    Habib, Adil
    McAfee, Jean
    Teachenor, Olga
    Tujague, Lauren
    Gonzalez, Stevan
    [J]. LIVER TRANSPLANTATION, 2016, 22 (03) : 281 - 286
  • [9] Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
    Loo, Jing Hong
    Xu, Wen Xin Flora
    Low, Jun Teck
    Tay, Wei Xuan
    Ang, Le Shaun
    Tam, Yew Chong
    Thurairajah, Prem Harichander
    Kumar, Rahul
    Wong, Yu Jun
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1248 - 1257
  • [10] Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
    Jing Hong Loo
    Wen Xin Flora Xu
    Jun Teck Low
    Wei Xuan Tay
    Le Shaun Ang
    Yew Chong Tam
    Prem Harichander Thurairajah
    Rahul Kumar
    Yu Jun Wong
    [J]. World Journal of Hepatology, 2022, 14 (06) : 1248 - 1257
12345